Categories AlphaGraphs, Earnings, Health Care
Abbott Laboratories (ABT) Q1 2025 Earnings: Key financials and quarterly highlights
Abbott Laboratories (NYSE: ABT) reported its first quarter 2025 earnings results today.
Total sales increased 4% year-over-year to $10.35 billion. Organic sales growth was 6.9%.
Net earnings grew 8.2% to $1.32 billion compared to last year. GAAP earnings per share increased 8.6% to $0.76 while adjusted EPS rose 11.2% to $1.09.
Abbott expects full-year 2025 organic sales growth to be 7.5-8.5% and adjusted EPS to be $5.05-5.25. For the second quarter of 2025, adjusted EPS is expected to be $1.23-1.27.
Prior performance
Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.
Most Popular
Key highlights from Pfizer’s (PFE) Q1 2025 earnings results
Pfizer Inc. (NYSE: PFE) reported its first quarter 2025 earnings results today. Revenues decreased 8% year-over-year to $13.7 billion. GAAP net income decreased 5% to $2.96 billion, or $0.52 per
PYPL Earnings: PayPal reports higher Q1 2025 revenue and profit
PayPal Holdings Inc. (NASDAQ: PYPL) on Tuesday reported a modest increase in revenue for the first quarter of 2025 when the payment service giant's adjusted earnings rose by double digits.
General Motors (GM) Q1 2025 revenue and adj. earnings beat estimates
Auto giant General Motors (NYSE: GM) on Tuesday announced financial results for the first quarter of 2025, reporting an increase in revenue and adjusted profit. The results also topped expectations.
